Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

IMP-13

Home DrugsIMP-13

IMP-13

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Preparation method of polyclonal antibody of cellular karyoplasms transferring acceptor protein 13
CN 1807596 AApplicant: UNIV XIAMENPriority: 2006
CN
Fragrance compositions
US 2008096790 A1Applicant: QUEST INT SERV BVPriority: 2006
US
一种1-取代-1H-咪唑-2-羧酸类化合物
CN 111253317 BApplicant: 四川大学Priority: 2020
CN
1-取代-1H-咪唑-2-羧酸类化合物在制备金属β-内酰胺酶抑制剂中的用途
CN 111187218 BApplicant: 四川大学Priority: 2020
CN